Management of renal cell carcinoma with ablation in comparison to nephrectomy: A 5-year analysis of inpatient procedural data to evaluate utilization disparities in the United States
Since 2016, there has been a decreasing trend in the use of ablation for treating RCC in hospitalized patients. Those undergoing ablation tend to be older, African American, Hispanic, and insured by Medicare or Medicaid. Further research is needed to ensure equitable access for optimal treatment of RCC.
Authors
- Raul N. Uppot (ORCID: https://orcid.org/0000-0001-6165-4911)
- Azadeh Tabari (ORCID: https://orcid.org/0000-0002-5685-6401)
- Michael Dezube
- Taha Lodhi (ORCID: https://orcid.org/0000-0002-6891-0866)
- Ronald S. Arellano (ORCID: https://orcid.org/0000-0001-9232-4069)
- Dania Daye (ORCID: https://orcid.org/0000-0002-2230-7199)
- Susan R. Davis (ORCID: https://orcid.org/0000-0002-2955-0415)
- Tarig Elhakim (ORCID: https://orcid.org/0000-0002-5038-9232)
- W. Fidelis (ORCID: https://orcid.org/0009-0002-6225-4244)
- Allison Brea
- Ana Mort
- Maryam Mohagheghtabar
Institutions
- Tufts University (US)
- Georgetown University (US)
- East Carolina University (US)
- Worcester State University (US)
- Massachusetts General Hospital (US)
- Saint Louis University (US)
Publication Details
- Journal
- Clinical Imaging
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1016/j.clinimag.2025.110412
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52